Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

INmune Bio Inc. - Common stock (NQ:INMB)

1.853 +0.123 (+7.13%)
Streaming Delayed Price Updated: 10:01 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 158,129
Open 1.750
Bid (Size) 1.850 (14)
Ask (Size) 1.860 (5)
Prev. Close 1.730
Today's Range 1.750 - 1.926
52wk Range 1.710 - 11.64
Shares Outstanding 17,703,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INMUNE BIO INC (NASDAQ:INMB) Reports Narrower-Than-Expected Q3 2025 Loss
INmune Bio (INMB) reported a narrower-than-expected Q3 2025 loss, sparking a positive after-hours market reaction for the clinical-stage biotech firm. 
Via Chartmill
Earnings Scheduled For October 30, 2025
 
Via Benzinga

Performance

YTD
-62.4%
-62.4%
1 Month
-10.5%
-10.5%
3 Month
-32.1%
-32.1%
6 Month
-75.6%
-75.6%
1 Year
-68.9%
-68.9%

More News

Read More
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
From INmune Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For August 7, 2025
Via Benzinga
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio (INMB) Q2 Loss Widens 110%
Via The Motley Fool
Topics Intellectual Property
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th
From INmune Bio, Inc.
Via GlobeNewswire
INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference
From INmune Bio, Inc.
Via GlobeNewswire
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
INmune Bio Rebounds Sharply During After Hours Trading: What's Driving the Surge?
Via Benzinga
INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference
From INmune Bio, Inc.
Via GlobeNewswire
'Pharma Bro' Martin Shkreli Says 'Good Chance' Inmune Bio Stock Will Slip 90% On Monday
Via Benzinga
Which stocks have an unusual volume on Thursday?
Via Chartmill
This Textron Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
From INmune Bio, Inc.
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Crude Oil Moves Lower; Joby Aviation Shares Surge
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Which stocks are moving on Monday?
Via Chartmill

Frequently Asked Questions

Is INmune Bio Inc. - Common stock publicly traded?
Yes, INmune Bio Inc. - Common stock is publicly traded.
What exchange does INmune Bio Inc. - Common stock trade on?
INmune Bio Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for INmune Bio Inc. - Common stock?
The ticker symbol for INmune Bio Inc. - Common stock is INMB on the Nasdaq Stock Market
What is the current price of INmune Bio Inc. - Common stock?
The current price of INmune Bio Inc. - Common stock is 1.853
When was INmune Bio Inc. - Common stock last traded?
The last trade of INmune Bio Inc. - Common stock was at 10/31/25 10:01 AM ET
What is the market capitalization of INmune Bio Inc. - Common stock?
The market capitalization of INmune Bio Inc. - Common stock is 32.81M
How many shares of INmune Bio Inc. - Common stock are outstanding?
INmune Bio Inc. - Common stock has 33M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.